Comparative analysis of plasma metabolomics markers in patients with major depressive disorder and healthy controls

INTRODUCTION: Mood disorders, including depression, are diseases associated with an increased risk of several metabolic alterations. Metabolomics studies have proved their potential for detecting novel biomarkers of psychiatric diseases. OBJECTIVES: To analyze the plasma metabolite profiling of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Homorogan, C., Nitusca, D., Enatescu, V., Moraru, C., Socaciu, C., Marian, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567226/
http://dx.doi.org/10.1192/j.eurpsy.2022.835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567226/
http://dx.doi.org/10.1192/j.eurpsy.2022.835

Ejemplares similares